Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard

Showing results (861-870 of 36,230) with videos related to

Pageof 3,623
Sort By:
Current Opinion in Allergy and Clinical Immunology|August 11, 2017
Ocular surface lubricantsLeonard Bielory, Preeti Wagle
Practical Radiation Oncology|October 3, 2017
Measuring safety culture: Application of the Hospital Survey on Patient Safety Culture to radiation therapy departments worldwideSarah Leonard, Anita O'Donovan
Cells|September 9, 2020
Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using NanocarriersLeonard Kaps, Detlef Schuppan
Proceedings. Biological Sciences|December 16, 2020
Determining cancer risk: the evolutionary multistage model or total stem cell divisions?Leonard Nunney, Kevin Thai
Current Allergy and Asthma Reports|March 1, 2019
Emerging Therapeutics for Ocular Surface DiseaseLeonard Bielory, Dovid Schoenberg
Methods (San Diego, Calif.)|February 19, 2019
Real-time monitoring of protein-induced DNA conformational changes using single-molecule FRETLeonard Schärfen, Michael Schlierf
Current Opinion in Allergy and Clinical Immunology|August 30, 2019
Ocular allergy: update on clinical trialsLeonard Bielory, Dovid Schoenberg
The American Journal of Geriatric Cardiology|March 10, 2006
Implantable cardioverter-defibrillators for secondary prevention: is it worth it in the elderly?Darren Traub, Leonard Ganz
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 8, 2008
Stereoconfiguration of antiallergic and immunologic drugsLeonard Bielory, Andrey Leonov
Antibiotics (Basel, Switzerland)|January 19, 2017
Thioridazine: A Non-Antibiotic Drug Highly Effective, in Combination with First Line Anti-Tuberculosis Drugs, against Any Form of Antibiotic Resistance of Mycobacterium tuberculosis Due to Its Multi-Mechanisms of ActionLeonard Amaral, Miguel Viveiros
Pageof 3,623

Showing results (861-870 of 36,230) with videos related to

Sort By:
Pageof 3,623
Current Opinion in Allergy and Clinical Immunology|August 11, 2017
Ocular surface lubricantsLeonard Bielory, Preeti Wagle
Practical Radiation Oncology|October 3, 2017
Measuring safety culture: Application of the Hospital Survey on Patient Safety Culture to radiation therapy departments worldwideSarah Leonard, Anita O'Donovan
Cells|September 9, 2020
Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using NanocarriersLeonard Kaps, Detlef Schuppan
Proceedings. Biological Sciences|December 16, 2020
Determining cancer risk: the evolutionary multistage model or total stem cell divisions?Leonard Nunney, Kevin Thai
Current Allergy and Asthma Reports|March 1, 2019
Emerging Therapeutics for Ocular Surface DiseaseLeonard Bielory, Dovid Schoenberg
Methods (San Diego, Calif.)|February 19, 2019
Real-time monitoring of protein-induced DNA conformational changes using single-molecule FRETLeonard Schärfen, Michael Schlierf
Current Opinion in Allergy and Clinical Immunology|August 30, 2019
Ocular allergy: update on clinical trialsLeonard Bielory, Dovid Schoenberg
The American Journal of Geriatric Cardiology|March 10, 2006
Implantable cardioverter-defibrillators for secondary prevention: is it worth it in the elderly?Darren Traub, Leonard Ganz
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 8, 2008
Stereoconfiguration of antiallergic and immunologic drugsLeonard Bielory, Andrey Leonov
Antibiotics (Basel, Switzerland)|January 19, 2017
Thioridazine: A Non-Antibiotic Drug Highly Effective, in Combination with First Line Anti-Tuberculosis Drugs, against Any Form of Antibiotic Resistance of Mycobacterium tuberculosis Due to Its Multi-Mechanisms of ActionLeonard Amaral, Miguel Viveiros
Pageof 3,623